Autolus Therapeutics (AUTL) director awarded new options and RSUs

Rhea-AI Filing Summary

Autolus Therapeutics plc director Ryan Richardson received new equity awards in the form of options and restricted share units. He was granted options to buy 47,500 American Depositary Shares at an exercise price of $1.61 per share, expiring on June 29, 2036. These options vest in twelve equal monthly installments starting on July 29, 2026. He also received 31,667 restricted share units, each representing one American Depositary Share, which vest in a single installment on June 29, 2027. Following these grants, his reported holdings for these awards match the granted amounts, reflecting compensation rather than open‑market trading.

Insights

Equity compensation analyst

Director received routine option and RSU grants as equity compensation.

Autolus Therapeutics granted director Ryan Richardson 47,500 stock options at an exercise price of $1.61 and 31,667 restricted share units. Both awards appear as standard, board-level equity compensation rather than open-market purchases or sales.

The options vest monthly over one year starting July 29, 2026, while the RSUs cliff-vest on June 29, 2027. Because there are no open-market transactions and no immediate cash consideration, the filing mainly updates Richardson’s long-term incentive position without signaling a change in his market view.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Richardson Ryan

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	31,667	$0.00	--
Grant/Award	Share Option (Right to Buy)	47,500	$0.00	--

Holdings After Transaction: Restricted Share Units — 31,667 shares (Direct, null); Share Option (Right to Buy) — 47,500 shares (Direct, null)

Footnotes (1)

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share. The RSUs vest in one installment on June 29, 2027. Share options vest in twelve equal monthly installments commencing on July 29, 2026.

Key Figures

Option grant size: 47,500 options Option exercise price: $1.61 per share Option expiration: June 29, 2036 +3 more

6 metrics

Option grant size 47,500 options Granted on June 29, 2026 to director Ryan Richardson

Option exercise price $1.61 per share Exercise price for 47,500 American Depositary Share options

Option expiration June 29, 2036 Expiration date of granted share options

RSU grant size 31,667 RSUs Restricted share units granted June 29, 2026

RSU vesting date June 29, 2027 Single cliff vesting date for RSU award

Option vesting schedule 12 monthly installments Vesting begins July 29, 2026

Key Terms

Restricted Share Units, American Depositary Shares, Share Option (Right to Buy)

3 terms

Restricted Share Units financial

"The RSUs vest in one installment on June 29, 2027."

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

American Depositary Shares financial

"Each restricted stock unit represents a contingent right to receive one share of the Issuer's American Depositary Shares."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Share Option (Right to Buy) financial

"security_title: "Share Option (Right to Buy)""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 04:17 PM Accepted by SEC EDGAR 07/01/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Richardson Ryan

(Last) (First) (Middle)

THE MEDIAWORKS, WHITE CITY

C/O AUTOLUS THERAPEUTICS PLC

(Street)

LONDON W12 7FP

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Autolus Therapeutics plc [ AUTL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	06/29/2026		A		31,667		(2)	(2)	American Depositary Shares	31,667	$0	31,667	D
Share Option (Right to Buy)	$1.61	06/29/2026		A		47,500		(3)	06/29/2036	American Depositary Shares	47,500	$0	47,500	D

Explanation of Responses:

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.

2. The RSUs vest in one installment on June 29, 2027.

3. Share options vest in twelve equal monthly installments commencing on July 29, 2026.

	/s/ Ryan Richardson	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Autolus Therapeutics (AUTL) report for Ryan Richardson?

Autolus Therapeutics reported that director Ryan Richardson received equity compensation grants, including 47,500 stock options at a $1.61 exercise price and 31,667 restricted share units, rather than buying or selling shares in open-market transactions.

How many stock options did Ryan Richardson receive from Autolus Therapeutics (AUTL)?

Ryan Richardson received 47,500 share options, each giving the right to buy one American Depositary Share at $1.61. These options are part of his director compensation and vest in twelve equal monthly installments beginning on July 29, 2026.

What restricted share unit award did Autolus Therapeutics (AUTL) grant to Ryan Richardson?

Autolus Therapeutics granted Ryan Richardson 31,667 restricted share units. Each RSU represents a contingent right to receive one American Depositary Share, with the entire award vesting in a single installment on June 29, 2027, subject to the standard RSU conditions.

When do Ryan Richardson’s new Autolus Therapeutics (AUTL) stock options vest?

Ryan Richardson’s new share options vest in twelve equal monthly installments starting on July 29, 2026. This means portions of the 47,500 options become exercisable each month over one year, aligning with typical director equity compensation schedules.

Do Ryan Richardson’s Autolus Therapeutics (AUTL) RSUs convert into ordinary shares?

Each restricted share unit converts into one American Depositary Share, and each American Depositary Share is convertible at any time, at Richardson’s option, into one ordinary share. This structure links his RSU awards directly to Autolus Therapeutics’ ordinary equity.

Does this Autolus Therapeutics (AUTL) Form 4 show any insider share sales or purchases?

The Form 4 does not show open-market share sales or purchases. It reports grants of 47,500 stock options and 31,667 restricted share units to director Ryan Richardson as compensation, both recorded with acquisition transaction codes rather than buy or sell codes.